BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Monteiro L, Mello FW, Warnakulasuriya S. Tissue biomarkers for predicting the risk of oral cancer in patients diagnosed with oral leukoplakia: A systematic review. Oral Dis 2020. [PMID: 33290585 DOI: 10.1111/odi.13747] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Jäwert F, Fehr A, Öhman J, Stenman G, Kjeller G. Recurrent copy number alterations involving EGFR, CDKN2A, and CCND1 in oral premalignant lesions. J Oral Pathol Med 2022. [PMID: 35488777 DOI: 10.1111/jop.13303] [Reference Citation Analysis]
2 Monteiro L, do Amaral B, Delgado L, Garcês F, Salazar F, Pacheco JJ, Lopes C, Warnakulasuriya S. Podoplanin Expression Independently and Jointly with Oral Epithelial Dysplasia Grade Acts as a Potential Biomarker of Malignant Transformation in Oral Leukoplakia. Biomolecules 2022;12:606. [DOI: 10.3390/biom12050606] [Reference Citation Analysis]
3 Pursanova AE, Kazarina LN, Kruglova IA, Zinovev SV, Utkin OV, Filatova EN. The fluorescent immunocytochemical diagnostics of precancerous diseases and cancer of the oral mucosa. Klin Lab Diagn 2022;67:219-26. [PMID: 35575395 DOI: 10.51620/0869-2084-2022-67-4-219-226] [Reference Citation Analysis]
4 Haj-hosseini N, Lindblad J, Hasséus B, Kumar VV, Subramaniam N, Hirsch J. Early Detection of Oral Potentially Malignant Disorders: A Review on Prospective Screening Methods with Regard to Global Challenges. J Maxillofac Oral Surg . [DOI: 10.1007/s12663-022-01710-9] [Reference Citation Analysis]
5 Rangel R, Pickering CR, Sikora AG, Spiotto MT. Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy. Front Immunol 2022;13:840923. [PMID: 35154165 DOI: 10.3389/fimmu.2022.840923] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ramos-garcía P, González-moles MÁ, Warnakulasuriya S. Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: A systematic review and meta-analysis. Oral Oncology 2022;126:105734. [DOI: 10.1016/j.oraloncology.2022.105734] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Truchard E, Bertolus C, Martinez P, Thomas E, Saintigny P, Foy JP. Identification of a Gene-Expression-Based Surrogate of Genomic Instability during Oral Carcinogenesis. Cancers (Basel) 2022;14:834. [PMID: 35159101 DOI: 10.3390/cancers14030834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Čēma I, Dzudzilo M, Kleina R, Franckevica I, Svirskis Š. Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues. Cancers (Basel) 2021;13:5739. [PMID: 34830890 DOI: 10.3390/cancers13225739] [Reference Citation Analysis]
9 Monteiro L, Silva P, Delgado L, Amaral B, Garcês F, Salazar F, Pacheco JJ, Lopes C, Bousbaa H, Warnakulasuriya S. Expression of spindle assembly checkpoint proteins BubR1 and Mad2 expression as potential biomarkers of malignant transformation of oral leukoplakia: an observational cohort study. Med Oral Patol Oral Cir Bucal 2021;26:e719-28. [PMID: 34704983 DOI: 10.4317/medoral.24511] [Reference Citation Analysis]
10 De Porras-Carrique T, González-Moles MÁ, Warnakulasuriya S, Ramos-García P. Depression, anxiety, and stress in oral lichen planus: a systematic review and meta-analysis. Clin Oral Investig 2021. [PMID: 34460001 DOI: 10.1007/s00784-021-04114-0] [Reference Citation Analysis]
11 Lorini L, Bescós Atín C, Thavaraj S, Müller-Richter U, Alberola Ferranti M, Pamias Romero J, Sáez Barba M, de Pablo García-Cuenca A, Braña García I, Bossi P, Nuciforo P, Simonetti S. Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific Therapies. Cancers (Basel) 2021;13:3696. [PMID: 34359597 DOI: 10.3390/cancers13153696] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
12 Pritzker KPH, Darling MR, Hwang JT, Mock D. Oral Potentially Malignant Disorders (OPMD): What is the clinical utility of dysplasia grade? Expert Rev Mol Diagn 2021;21:289-98. [PMID: 33682567 DOI: 10.1080/14737159.2021.1898949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]